Figure S1. Correlation between intrathecal markers in isolated optic neuritis. This figure depicts the same, albeit much weaker or even absent correlations as shown for patients who later converted to multiple sclerosis (MS-ON) in Fig. 4. (PDF 123 kb
Details of the CSF samples taken for the study. Table S1 describes the age and gender of the subject...
Histogram of the flow cytometry for healthy control (A), MOG-IgG-positive sera with a dilution of 1:...
Chemokine and cytokine levels in CSF and peripheral blood. The Wilcoxon signed ranked test was used ...
Table S1. Logistic regression analyses for single predictors. Highlighted in bold are p values for w...
Figure S2. Receiver-operating characteristic (ROC) curves for the six individual predictors that wer...
Figure S5. Receiver-operating characteristic (ROC) for models predicting the conversion of optic neu...
Figure S3.(Aâ+âB) Calibration plots for the prediction models presented as nomograms. The calibr...
A schematic drawing indicating measurement of each part of the hindbrain. 1. Vertical diameter of ve...
Table S1. Neurodegenerative and neuroinflammatory markers in CSF (and for NFL also in serum) over ti...
Table S1. Clinical and demographic data of the MS patients and non-neurological disease controls (PD...
Table S2. Neuroinflammatory and neurodegenerative markers with respect to separation of patients wit...
NPY-Y1R+ axon undergoing Wallerian degeneration do not co-localize with hypophosphorylated and low-m...
Table S1. Neuropsychological testing of the patient at ages 23, 25, and 27 years. (DOC 38 kb
Table S1. Comparison of levels of phosphorylated proteins between MS patients and controls in baseli...
Histogram of the flow cytometry and geometric mean fluorescence (G-mean) ratio for healthy control a...
Details of the CSF samples taken for the study. Table S1 describes the age and gender of the subject...
Histogram of the flow cytometry for healthy control (A), MOG-IgG-positive sera with a dilution of 1:...
Chemokine and cytokine levels in CSF and peripheral blood. The Wilcoxon signed ranked test was used ...
Table S1. Logistic regression analyses for single predictors. Highlighted in bold are p values for w...
Figure S2. Receiver-operating characteristic (ROC) curves for the six individual predictors that wer...
Figure S5. Receiver-operating characteristic (ROC) for models predicting the conversion of optic neu...
Figure S3.(Aâ+âB) Calibration plots for the prediction models presented as nomograms. The calibr...
A schematic drawing indicating measurement of each part of the hindbrain. 1. Vertical diameter of ve...
Table S1. Neurodegenerative and neuroinflammatory markers in CSF (and for NFL also in serum) over ti...
Table S1. Clinical and demographic data of the MS patients and non-neurological disease controls (PD...
Table S2. Neuroinflammatory and neurodegenerative markers with respect to separation of patients wit...
NPY-Y1R+ axon undergoing Wallerian degeneration do not co-localize with hypophosphorylated and low-m...
Table S1. Neuropsychological testing of the patient at ages 23, 25, and 27 years. (DOC 38 kb
Table S1. Comparison of levels of phosphorylated proteins between MS patients and controls in baseli...
Histogram of the flow cytometry and geometric mean fluorescence (G-mean) ratio for healthy control a...
Details of the CSF samples taken for the study. Table S1 describes the age and gender of the subject...
Histogram of the flow cytometry for healthy control (A), MOG-IgG-positive sera with a dilution of 1:...
Chemokine and cytokine levels in CSF and peripheral blood. The Wilcoxon signed ranked test was used ...